Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

BACKGROUND: SARS-CoV-2 vaccines currently authorized for emergency use have been highly successful in preventing infection and lessening disease severity. The vaccines maintain effectiveness against earlier SARS-CoV-2 Variants of Concern but the heavily mutated, highly transmissible Omicron variant...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Takuya, Zhou, Hao, Dcosta, Belinda M., Samanovic, Marie I., Chivukula, Vidya, Herati, Ramin S., Hubbard, Stevan R., Mulligan, Mark J., Landau, Nathaniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021600/
https://www.ncbi.nlm.nih.gov/pubmed/35465948
http://dx.doi.org/10.1016/j.ebiom.2022.103944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021600/
https://www.ncbi.nlm.nih.gov/pubmed/35465948
http://dx.doi.org/10.1016/j.ebiom.2022.103944

Ejemplares similares